Immune Effector Cell Therapy in Hematologic Malignancies: Lessons Learned with Babis Andreadis and Ajai Chari
Grand Rounds
Department of Medicine Grand Rounds
-
The fields of bone marrow transplantation and malignant hematology have been transformed in recent years. In this Grand Rounds, we will explore novel therapies, such as the use of immune effector cells in hematological malignancies. We will discuss the rationale behind these treatments and practical clinical pearls in the management of patients with hematologic malignancies.
Speakers
Babis Andreadis, MD, MS, is a professor in the Division of Hematology and Oncology at UCSF Health and director of the Baszucki Lymphoma Therapeutic Initiative for the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include drug toxicity and genetic and patient factors behind differential responses to therapy.
Ajai Chari, MD, is also a professor in the Division of Hematology and Oncology at UCSF Health. He is also the director of the Multiple Myeloma Program. His research interests include the development of novel chemotherapy regimens, including Phase 1 and 2 national and international trials.
How to Attend
In Person:
N-217 (Nursing Building, enter through 521 Parnassus Avenue)
Lunch will be provided
By Phone (for higher quality, dial a number based on your current location):
US: +1 669 900 6833 or +1 346 248 7799 or +1 312 626 6799 or
+1 646 558 8656 or +1 253 215 8782 or +1 301 715 8592
International numbers available: https://ucsf.zoom.us/u/abBh6VatYU
Add to Calendar2024-04-11 19:00:002024-04-11 20:00:00Immune Effector Cell Therapy in Hematologic Malignancies: Lessons Learned with Babis Andreadis and Ajai Chari
The fields of bone marrow transplantation and malignant hematology have been transformed in recent years. In this Grand Rounds, we will explore novel therapies, such as the use of immune effector cells in hematological malignancies. We will discuss the rationale behind these treatments and practical clinical pearls in the management of patients with hematologic malignancies.
Speakers
Babis Andreadis, MD, MS, is a professor in the Division of Hematology and Oncology at UCSF Health and director of the Baszucki Lymphoma Therapeutic Initiative for the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include drug toxicity and genetic and patient factors behind differential responses to therapy.
Ajai Chari, MD, is also a professor in the Division of Hematology and Oncology at UCSF Health. He is also the director of the Multiple Myeloma Program. His research interests include the development of novel chemotherapy regimens, including Phase 1 and 2 national and international trials.
How to Attend
In Person:
N-217 (Nursing Building, enter through 521 Parnassus Avenue)
Lunch will be provided
On Zoom:
Join from a PC, Mac, iPad, iPhone or Android device:
https://ucsf.zoom.us/j/93868706312?pwd=ZWpzeHlNYmJzcUp3c1JxRWpyTGF2QT09
Webinar ID: 938 6870 6312
Passcode: 249803
By Phone (for higher quality, dial a number based on your current location):
US: +1 669 900 6833 or +1 346 248 7799 or +1 312 626 6799 or
+1 646 558 8656 or +1 253 215 8782 or +1 301 715 8592
International numbers available: https://ucsf.zoom.us/u/abBh6VatYU
Action Research Center (ARC) for Health EquityAmerica/Los_Angelespublic
